Pegacaristim

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegacaristim
Drug Alias NameMGDFKRN 9000Polyethylene glycolconjugated recombinant human megakaryocyte growth and development factorPegylated recombinant megakaryocyte growth and development factorPegylated megakaryocyte growth and development factor +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionThrombopoietin receptor agonists
TargetsThrombopoietin receptor
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKirinAmgen IncZymogenetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKirinZymogenetics IncAmgen Inc
Active IndicationsN/A
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsThrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A